This global trial had been ongoing for 14 months and enrollment was slow due to logistical complexities associated with fresh tumor sample collection & access to a leukapheresis lab.

The client had been told by their CRO that expansion to Canada was not a good option due to a lack of investigator interest and limited lab capabilities.

See how Canada started-up 5 sites in just over 9 weeks while recruiting 4.67 patients per site compared with 1.82 in Europe.